129
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Risk of Arterial and Venous Thromboembolic Events Among Patients with Colorectal Carcinoma: a Real-World, Population-Based Study

ORCID Icon, &
Pages 3977-3986 | Received 28 Feb 2021, Accepted 29 Jun 2021, Published online: 03 Aug 2021

References

  • Araghi M , SoerjomataramI, JenkinsMet al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer144(12), 2992–3000 (2019).
  • Abdel-Rahman O . Patterns and trends of cancer screening in canada: results from a contemporary national survey. J. Natl. Compr. Canc. Netw.19(1), 68–76 (2021).
  • Click B , PinskyPF, HickeyTet al. Association of colonoscopy adenoma findings with long-term colorectal cancer incidence. JAMA319(19), 2021–2031 (2018).
  • Mahajan A , BrunsonA, WhiteR, WunT. The epidemiology of cancer-associated venous thromboembolism: an update. Semin. Thromb. Hemost.45(4), 321–325 (2019).
  • Arnold M , SierraMS, LaversanneMet al. Global patterns and trends in colorectal cancer incidence and mortality. Gut66(4), 683–691 (2017).
  • Hisada Y , MackmanN. Cancer-associated pathways and biomarkers of venous thrombosis. Blood130(13), 1499–1506 (2017).
  • Campello E , IlichA, SimioniP, KeyNS. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br. J. Cancer121(5), 359–371 (2019).
  • Zhang M , WuS, HuC. Do lung cancer patients require routine anticoagulation treatment? A meta-analysis. J. Int. Med. Res.48(1), doi: 10.1177/0300060519896919 (2020).
  • Repetto O , DeRe V. Coagulation and fibrinolysis in gastric cancer. Ann. N. Y. Acad. Sci.1404(1), 27–48 (2017).
  • Key NS , KhoranaAA, KudererNMet al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol38(5), 496–520 (2020).
  • Kahale LA , HakoumMB, TsolakianIGet al. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Cochrane Database Syst. Rev.6(6), Cd006650 (2018).
  • Hanley DF , ThompsonRE, RosenblumMet al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet393(10175), 1021–1032 (2019).
  • Raskob GE , Van EsN, VerhammePet al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N. Engl. J. Med.378(7), 615–624 (2018).
  • Young AM , MarshallA, ThirlwallJet al. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol36(20), 2017–2023 (2018).
  • Maissenhaelter BE , WoolmoreAL, SchlagPM. Real-world evidence research based on big data: motivation-challenges-success factors. Onkologe (Berl).24(Suppl. 2), 91–98 (2018).
  • Alberta Health Services . (2020). https://www.albertahealthservices.ca/assets/about/publications/ahs-ar-2020/zones.html
  • Abdol Razak NB , JonesG, BhandariMet al. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers (Basel)10(10), 380 (2018).
  • Abdel-Rahman O , SpratlinJ, KoskiS. Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma. Med.Oncol.38(2), 18 (2021).
  • Slater J , GreenC, SevenhuysenGet al. Socio-demographic and geographic analysis of overweight and obesity in Canadian adults using the Canadian Community Health Survey (2005). Chronic Dis. Can.30(1), 4–15 (2009).
  • Corsi DJ , ChowCK, LearSAet al. Smoking in context: a multilevel analysis of 49,088 communities in Canada. Am. J. Prev. Med.43(6), 601–610 (2012).
  • Faioni EM , ZighettiML, VozzoNP. Sex, gender and venous thromboembolism: do we care enough?Blood Coagul. Fibrinolysis29(8), 663–667 (2018).
  • Van Es N , VentrescaM, DiNisio Met al. The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis. J. Thromb. Haemost.18(8), 1940–1951 (2020).
  • Khorana AA , KudererNM, CulakovaEet al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood111(10), 4902–4907 (2008).
  • Cohen AT , KatholingA, RietbrockSet al. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb. Haemost.117(1), 57–65 (2017).
  • Abdel-Rahman O , KoskiS, MulderK. Real-world patterns of chemotherapy administration and attrition among patients with metastatic colorectal cancer. Int. J. Colorectal. Dis.doi:10.1007/s00384-020-03778-6 (2020).
  • Nalluri SR , ChuD, KeresztesRet al. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA300(19), 2277–2285 (2008).
  • Blom JW , DoggenCJ, OsantoS, RosendaalFR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA293(6), 715–722 (2005).
  • Trousseau A . Phlegmasia alba dolens. Clin. Med. l'Hotel-Dieu de Paris3, 94 (1865).
  • Bouillaud S , BouillaudJ. De l'Obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general. Arch Gen Med1(2), 188–204 (1823).
  • De Stefano V . Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome. Haematologica103(9), 1419–1421 (2018).
  • Grilz E , KönigsbrüggeO, PoschFet al. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. Haematologica103(9), 1549–1556 (2018).
  • Oweira H , GiryesA, MannhartMet al. Impact of time to start systemic therapy on the outcomes of patients with metastatic colorectal cancer treated with first line FOLFOX Chemotherapy; a Patient-level pooled analysis of two clinical trials. Expert Rev. Gastroenterol. Hepatol.12(10), 1069–1074 (2018).
  • Alberta Government . (2021). https://www.alberta.ca/population-statistics.aspx

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.